Member Registration

Non-Member Registration

See Our List of Current Members

In January 2024, Ashley Magargee assumed the role of chief executive officer of Genentech, a member of the Roche Group, and also joined Genentech’s Board of Directors. As ​CEO, Ashley’s primary responsibilities are to provide strategic leadership for Genentech, cultivate a vibrant culture that inspires employees to be their best, and bring life-changing ​medicines to patients.

Ashley was previously head of the Commercial Portfolio Organization, responsible for the overall performance of Genentech’s approved medicines in the United States. During her ​tenure in this role, she successfully launched numerous groundbreaking medicines for people with serious conditions and also expanded the company’s

presence in several therapeutic areas.

Throughout her nearly two-decade career at Genentech and Roche, Ashley has led global cross-functional teams to develop and commercialize innovative medicines worldwide. ​She has also been instrumental in shaping the company’s digital customer engagement strategy and has held leadership positions in access, marketing and sales for therapeutic ​areas such as hematology, lung cancer and transplant. Additionally, Ashley served as the general manager for Roche’s commercial operations in Singapore and Brunei.

Early in her career, Ashley worked on Capitol Hill, focusing on health policy under Senator Tom Daschle, the Democratic Leader of the U.S. Senate. She also served as assistant ​principal at the St. Mark the Evangelist School in Harlem, where she witnessed firsthand the profound impact of sickle cell disease on her students. These experiences in public ​service laid a strong foundation for Ashley’s subsequent transition into the biopharmaceutical industry. Here, she has sought to leverage the industry’s innovation, reach and ​resources to bring about transformative medicines and healthcare solutions for patients in critical need.

Ashley is a firm believer that encouraging a diversity of backgrounds, thoughts and experiences is critical to fueling scientific and customer innovation. She is dedicated to ​cultivating an environment where all employees are included and empowered; advancing Genentech’s commitment to inclusive research and health equity; and transforming ​society through sustainable solutions that address inequities in healthcare, advance STEM education and support Genentech’s local communities.

Ashley serves on the Board of Directors for the Pharmaceutical Research and Manufacturers of America. She graduated from Princeton University and earned her MBA from ​Harvard University. Ashley resides in the San Francisco Bay Area with her husband and three sons.

Follow Ashley on LinkedIn to see her latest updates

Dr. Lungren is Chief Data Science Officer for Microsoft Health & Life Sciences where he focuses on translating cutting edge technology, including generative AI and cloud services, into innovative healthcare applications. As a physician and clinical machine learning researcher, he maintains collaborative research and teaching roles as adjunct professor at Stanford University.

Prior to joining Microsoft, Dr Lungren was a clinical interventional radiologist and research faculty at Stanford University Medical School where he led the Stanford Center for Artificial Intelligence in Medicine and Imaging (AIMI). He later served as Principal for Clinical AI/ML at Amazon Web Services in World Wide Public Sector Healthcare, focusing on business development for clinical machine learning technologies in the public cloud.

His scientific work has led to more than 200 publications, including work on multi-modal data fusion models for healthcare applications, new computer vision and natural language processing approaches for healthcare specific domains, opportunistic screening with machine learning for public health applications, open medical data as public good, prospective clinical trials for clinical AI translation, and application of generative AI in healthcare. He has served as advisor for early stage startups and large fortune-500 companies on healthcare AI technology development and go-to-market strategy. Dr. Lungren's work has been featured in national news outlets such as NPR, Vice News, Scientific American, and he regularly speaks at national and international scientific meetings on the topic of AI in healthcare.

Dr. Lungren is also a top rated instructor leading AI in Healthcare courses designed especially for learners with non-technical backgrounds:

Stanford/Coursera: https://www.coursera.org/learn/fundamental-machine-learning-healthcare

LinkedIn Learning: https://www.linkedin.com/learning/an-introduction-to-how-generative-ai-will-transform-healthcare

Member Registration

Non-Member Registration